---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-018687"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-05-09T23:59:59+00:00"
generated_at: "2026-06-25T22:40:44.320496+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD effects 1-for-50 reverse stock split; authorized shares cut to 12M

## Summary
- Reverse split effective May 6, 2022; every 50 shares become 1 share.
- Authorized shares reduced from 600M to 12M; fractional shares rounded up.
- Trading on split-adjusted basis under TXMD begins May 9, 2022.
- No stockholder approval required under Nevada law.

## SEC filing metadata
- accession: 0001564590-22-018687
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000156459022018687/0001564590-22-018687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000156459022018687/txmd-8k_20220503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-018687
- JSON: https://secwatch.observer/filing/0001564590-22-018687.json
- Plain text: https://secwatch.observer/filing/0001564590-22-018687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.